Asian Journal of Pharmaceutical Sciences
Scope & Guideline
Advancing pharmaceutical knowledge for a healthier tomorrow.
Introduction
Aims and Scopes
- Innovative Drug Delivery Systems:
The journal emphasizes the development of novel drug delivery systems, including nanocarriers, hydrogels, and microneedles, to enhance the bioavailability and efficacy of therapeutic agents. - Nanotechnology in Medicine:
A significant focus is placed on the application of nanotechnology in medicine, particularly in creating nanoparticles for targeted therapy, imaging, and diagnostics, thus improving treatment outcomes. - Therapeutic Strategies for Chronic Diseases:
Research addressing therapeutic strategies for chronic diseases, including cancer, diabetes, and inflammatory conditions, is a core area, with an emphasis on personalized medicine and combination therapies. - Biomaterials and Regenerative Medicine:
The journal covers advancements in biomaterials and their applications in tissue engineering and regenerative medicine, exploring their potential in drug delivery and wound healing. - Extracellular Vesicles and Stem Cell Applications:
There is a growing interest in the use of extracellular vesicles and stem cells for therapeutic applications, particularly in the context of regenerative medicine and targeted drug delivery.
Trending and Emerging
- Nanomedicine and Targeted Therapy:
A significant increase in research focused on nanomedicine and targeted therapeutic strategies highlights the journal's direction towards improving drug efficacy and minimizing side effects through precision medicine. - Smart Drug Delivery Systems:
Emerging themes around smart and stimuli-responsive drug delivery systems are gaining traction, showcasing advancements in technology that allow for controlled and on-demand release of therapeutics. - Immunotherapy and Cancer Treatment:
There is a notable rise in publications addressing immunotherapy, particularly in cancer treatment, reflecting a shift towards harnessing the body's immune system to combat malignancies. - Regenerative Medicine and Tissue Engineering:
Research on regenerative medicine and the use of biomaterials for tissue engineering is increasingly prominent, indicating a growing interest in developing solutions for complex tissue repair and regeneration. - Gene Therapy and CRISPR Technologies:
The exploration of gene therapy approaches, including CRISPR technologies, is becoming more prevalent, reflecting the journal's focus on innovative techniques to address genetic disorders and enhance therapeutic outcomes.
Declining or Waning
- Traditional Pharmaceutical Formulations:
Research focusing on conventional pharmaceutical formulations, such as tablets and capsules, is becoming less prominent as newer, more innovative drug delivery systems gain attention. - Basic Pharmacology Studies:
Studies that primarily focus on basic pharmacological mechanisms without a strong translational aspect are waning, as the journal shifts towards more applied research with direct clinical relevance. - In vitro Drug Testing Models:
There is a noticeable decline in papers utilizing traditional in vitro drug testing models, as researchers increasingly favor more complex, relevant models that better mimic in vivo conditions. - Nutraceuticals and Herbal Medicine:
While still relevant, the emphasis on nutraceuticals and herbal medicines seems to be decreasing, possibly due to a growing focus on synthetic and biopharmaceuticals in therapeutic research. - Single-Drug Therapies:
The focus on single-drug therapies is diminishing as combination therapies and multi-target approaches become more favored in treating complex diseases.
Similar Journals
VIEW
Uniting Global Scholars in Biomedical Engineering Advancement.VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.
ADVANCED DRUG DELIVERY REVIEWS
Leading the Charge in Pharmaceutical Advancements.ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
Delivering essential insights into pharmacological advancements.Indian Journal of Pharmaceutical Sciences, with ISSN 0250-474X and E-ISSN 1998-3743, is a notable publication in the field of Pharmaceutical Sciences, published by the esteemed Indian Pharmaceutical Association. Established in 1978, this journal has been pivotal in disseminating innovative research findings and advancements in pharmaceutical sciences for over four decades. Though no longer covered in Scopus post-2022, its contributions through published works remain relevant to the academic community, ranking in the bottom half of the Scopus percentile for the pharmaceutical category. The journal offers a valuable platform for researchers, professionals, and students to share knowledge and foster collaboration, with a focus on novel methodologies, pharmacological studies, and toxicology. While the journal is not Open Access, it provides essential insights into the evolving landscape of pharmaceutical sciences, making it a key resource for anyone involved in this dynamic field.
Advanced Pharmaceutical Bulletin
Elevating Standards in Pharmaceutical InquiryAdvanced Pharmaceutical Bulletin, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, serves as a pivotal platform for disseminating groundbreaking research in the field of pharmaceutical sciences. Since its inception in 2011, this open-access journal has dedicated itself to advancing knowledge in pharmacology, toxicology, and pharmaceutics, boasting an impressive Q1 ranking in miscellaneous categories and Q2 in pharmaceutical science as of 2023. The journal is noted for its rigorous peer-review process, ensuring that published work meets the highest standards of scientific inquiry. With notable rankings, including 7th out of 80 in general pharmacology and toxicology, it sits in the 91st percentile, highlighting its significance in the research community. Researchers and practitioners alike can access cutting-edge findings and innovative methodologies, promoting collaboration and knowledge within the scientific community. Based in Tabriz, Iran, the journal remains committed to fostering research excellence, making it an invaluable resource for scholars and professionals eager to contribute to the dynamic field of pharmaceuticals.
International Journal of Pharmaceutics-X
Transforming discoveries into solutions for global health.International Journal of Pharmaceutics-X is a premier open access journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmaceutical sciences. Launched in 2019, this journal has quickly ascended to the Q1 category in the 2023 Category Quartiles, reflecting its high impact and the quality of research it promotes. With a current Scopus ranking of #49 out of 183 in the Pharmacology, Toxicology and Pharmaceutics category, this journal occupies the 73rd percentile, showcasing its significant influence within the scholarly community. Emphasizing innovative research and novel applications, the International Journal of Pharmaceutics-X offers a platform for researchers, professionals, and students to disseminate their findings, making crucial contributions to the global pharmaceutical landscape. The journal is based in the Netherlands, presenting a vibrant hub for scientific discourse and collaboration in a rapidly evolving field.
International Journal of Pharmaceutical Investigation
Fostering Dialogue on Cutting-Edge Pharmaceutical PracticesInternational Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.
Theranostics
Exploring the Intersection of Therapy and Diagnostics.Theranostics is a premier journal in the field of Medicine and Pharmacology, published by IVYSPRING INT PUBL. With its commitment to open access since 2011, it facilitates the widespread dissemination of innovative research, fostering collaboration and advancements in therapeutic diagnostics. The journal proudly holds a Q1 ranking in both Medicine (Miscellaneous) and Pharmacology, Toxicology and Pharmaceutics, as of 2023, showcasing its esteemed position within the scientific community. Recognized globally, it ranks in the top 1%, with Scopus rankings placing it as 4th out of 398 in Medicine and 1st out of 43 in Pharmacology. Theranostics serves as a crucial platform for researchers, professionals, and students to explore cutting-edge developments as it converges multidisciplinary approaches to enhance patient care and treatment efficacy. With a focus on bridging experimental research and clinical applications, the journal is instrumental in shaping future therapies and diagnostic strategies.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Shaping the Future of Pharmacology and ToxicologyThe Journal of Drug Delivery Science and Technology, published by Elsevier, stands at the forefront of pharmaceutical research, focusing on innovative drug delivery systems and technologies. With a robust impact factor reflected in its Q1 rating within the pharmaceutical sciences category, this journal is recognized for its high-quality contributions, ranking #30 out of 183 in the Scopus pharmacology and toxicology category (2023). Since its inception in 2004, the journal has been pivotal in disseminating groundbreaking research and advancements in drug formulation and delivery methodologies. Researchers and practitioners alike benefit from its comprehensive articles, which are accessible under open access options, ensuring widespread dissemination of knowledge. As it converges towards its 20th anniversary in 2024, the journal continues to enhance its impact on the scientific community, paving the way for future innovations in drug delivery.
JOURNAL OF PHARMACEUTICAL SCIENCES
Connecting scholars and professionals to drive pharmaceutical excellence.The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
Illuminating the path to effective drug delivery.CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS is an esteemed academic journal published by BEGELL HOUSE INC, focusing on the innovative field of drug delivery systems and therapeutic carriers. With an ISSN of 0743-4863 and E-ISSN 2162-660X, this journal serves as a pivotal resource for researchers, professionals, and students engaged in pharmaceutical sciences and pharmacology. Spanning from 1984 to 2024, it has sustained its relevance in an evolving landscape, holding a commendable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science, as well as a Q3 ranking in Pharmacology for 2023. The journal is well-regarded for its critical and comprehensive reviews that enhance understanding and drive advancements in therapeutic applications. Access options are variable, providing insights into contemporary practices and innovations that shape drug delivery strategies. With a strong emphasis on interdisciplinary approaches, CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS not only fosters scholarly dialogue but also propels forward the critical field of therapeutic delivery, making it a valuable asset for anyone looking to deepen their knowledge and influence within this dynamic area of study.